

House
Study
Bill
607
-
Introduced


HOUSE
FILE
_____


BY
(PROPOSED
COMMITTEE


ON
COMMERCE
BILL
BY


CHAIRPERSON
COWNIE)


A
BILL
FOR


An
Act
relating
to
the
medical
cannabidiol
Act,
making
related
1


modifications,
providing
for
civil
and
criminal
penalties
2


and
fees,
and
including
effective
date
provisions.
3


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
4


TLSB
6011YC
(3)
86


rh/rj



H.F.
_____


Section
1.
Section
124.204,
subsection
4,
paragraphs
m
and
1


u,
Code
2016,
are
amended
by
striking
the
paragraphs.
2


Sec.
2.
Section
124.204,
subsection
7,
Code
2016,
is
amended
3


by
striking
the
subsection.
4


Sec.
3.
Section
124.206,
subsection
7,
Code
2016,
is
amended
5


to
read
as
follows:
6


7.
Hallucinogenic
substances.
Unless
specifically
excepted
7


or
unless
listed
in
another
schedule,
any
material,
compound,
8


mixture,
or
preparation
which
contains
any
quantity
of
the
9


following
substances
,
or,
for
purposes
of
paragraphs


“a”
and
10


“b”


,
which
contains
any
of
its
salts,
isomers,
or
salts
of
11


isomers
whenever
the
existence
of
such
salts,
isomers,
or
salts
12


of
isomers
is
possible
within
the
specific
chemical
designation
13


(for
purposes
of
this
unnumbered
paragraph
only,
the
term


14


“isomers”
includes
the
optical,
positional,
and
geometric
15


isomers)
:
16


a.
Marijuana
when
used
for
medicinal
purposes
pursuant
to
17


rules
of
the
board


.
18


b.


Tetrahydrocannabinols,
meaning
tetrahydrocannabinols
19


naturally
contained
in
a
plant
of
the
genus
Cannabis
(Cannabis
20


plant)
as
well
as
synthetic
equivalents
of
the
substances


21


contained
in
the
Cannabis
plant,
or
in
the
resinous
extractives
22


of
such
plant,
and
synthetic
substances,
derivatives,
and
their


23


isomers
with
similar
chemical
structure
and
pharmacological
24


activity
to
those
substances
contained
in
the
plant,
such
as
25


the
following:
26


(1)
1
cis
or
trans
tetrahydrocannabinol,
and
their
optical
27


isomers.
28


(2)
6
cis
or
trans
tetrahydrocannabinol,
and
their
optical
29


isomers.


30


(3)
3,4
cis
or
trans
tetrahydrocannabinol,
and
their
31


optical
isomers.
(Since
nomenclature
of
these
substances


32


is
not
internationally
standardized,
compounds
of
these
33


structures,
regardless
of
numerical
designation
of
atomic


34


positions
covered.)
35


-1-


LSB
6011YC
(3)
86


rh/rj


1/
25









































H.F.
_____


b.
c.
Nabilone
[another
name
for
1


nabilone:
(+-)
-
2


trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-
3


hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one].
4


Sec.
4.
Section
124.401,
subsection
5,
unnumbered
paragraph
5


3,
Code
2016,
is
amended
to
read
as
follows:
6


A
person
may
knowingly
or
intentionally
recommend,
possess,
7


use,
dispense,
deliver,
transport,
or
administer
medical


8


cannabidiol
if
the
recommendation,
possession,
use,
dispensing,
9


delivery,
transporting,
or
administering
is
in
accordance
with
10


the
provisions
of
chapter
124D


124E
.
For
purposes
of
this
11


paragraph,
“cannabidiol”
“medical
cannabidiol”
means
the
same
as
12


defined
in
section
124D.2
124E.2
.
13


Sec.
5.
NEW
SECTION


.
124E.1
Short
title.
14


This
chapter
shall
be
known
and
may
be
cited
as
the
“Medical
15


Cannabidiol
Act”
.
16


Sec.
6.
NEW
SECTION
.
124E.2
Definitions.
17


As
used
in
this
chapter:
18


1.
“Debilitating
medical
condition”
means
any
of
the
19


following:
20


a.
Cancer,
if
the
underlying
condition
or
treatment
produces
21


one
or
more
of
the
following:
22


(1)
Intractable
pain.
23


(2)
Nausea
or
severe
vomiting.
24


(3)
Cachexia
or
severe
wasting.
25


b.
Multiple
sclerosis.
26


c.
Epilepsy
or
seizure
disorders.
27


d.
AIDS
or
HIV
as
defined
in
section
141A.1.


28


e.
Hepatitis
C.
29


f.
Crohn’s
disease
or
ulcerative
colitis.
30


g.
Amyotrophic
lateral
sclerosis.
31


h.
Ehlers-danlos
syndrome.
32


i.
Post-traumatic
stress
disorder.


33


j.
Any
terminal
illness,
with
a
probable
life
expectancy
of
34


under
one
year,
if
the
illness
or
its
treatment
produces
one
or
35


-2-


LSB
6011YC
(3)
86


rh/rj


2/
25














H.F.
_____


more
of
the
following:
1


(1)
Intractable
pain.
2


(2)
Nausea
or
severe
vomiting.
3


(3)
Cachexia
or
severe
wasting.
4


k.
Any
intractable
pain.
5


l.
Any
other
chronic
or
debilitating
disease
or
medical
6


condition
or
its
medical
treatment
approved
by
the
department
7


pursuant
to
rule.
8


2.
“Department”
means
the
department
of
public
health.
9


3.
“Disqualifying
felony
offense”
means
a
violation
under
10


federal
or
state
law
of
a
felony
under
federal
or
state
law,
11


which
has
as
an
element
the
possession,
use,
or
distribution
of
12


a
controlled
substance,
as
defined
in
21
U.S.C.
§802(6).
13


4.
“Enclosed,
locked
facility”
means
a
closet,
room,
14


greenhouse,
or
other
enclosed
area
equipped
with
locks
or
other
15


security
devices
that
permit
access
only
by
a
cardholder.
16


5.
“Health
care
practitioner”
means
an
individual
licensed
17


under
chapter
148
to
practice
medicine
and
surgery
or
18


osteopathic
medicine
and
surgery
or
an
out-of-state
licensed
19


physician
who
provides
specialty
care
for
a
resident
of
this
20


state
for
one
or
more
debilitating
medical
conditions.
21


6.
“Intractable
pain”
means
a
pain
the
cause
of
which
22


cannot
be
removed
or
otherwise
treated
with
the
consent
of
the
23


patient
and
of
or
for
which,
in
the
generally
accepted
course
24


of
medical
practice,
no
relief
or
cure
is
possible
or
no
relief
25


or
cure
has
been
found
after
reasonable
efforts.
Reasonable
26


efforts
for
relieving
the
pain
or
curing
the
cause
of
the
pain
27


may
be
determined
on
the
basis
of,
but
are
not
limited
to,
any
28


of
the
following:
29


a.
When
treating
a
non-terminally
ill
patient
for
30


intractable
pain,
evaluation
by
the
attending
physician
and
31


one
or
more
physicians
specializing
in
pain
medicine
or
in
the
32


treatment
of
the
area,
system,
or
organ
of
the
body
perceived
33


as
the
source
of
the
pain.
34


b.
When
treating
a
terminally
ill
patient,
evaluation
by
35


-3-


LSB
6011YC
(3)
86


rh/rj


3/
25



H.F.
_____


the
attending
physician
who
treats
the
patient
in
accordance
1


with
the
level
of
care,
skill,
and
treatment
that
would
be
2


recognized
by
a
reasonably
prudent
physician
under
similar
3


conditions
and
circumstances.
4


7.
“Medical
cannabidiol”
means
a
nonpsychoactive
cannabinoid
5


found
in
the
plant
Cannabis
sativa
L.
or
Cannabis
indica
or
any
6


other
preparation
thereof
that
is
essentially
free
from
plant
7


material,
and
has
a
tetrahydrocannabinol
level
of
no
more
than
8


three
percent.
9


8.
“Medical
cannabidiol
dispensary”
means
an
entity
licensed
10


under
section
124E.8
that
acquires
medical
cannabidiol
from
a
11


medical
cannabidiol
manufacturer
in
this
state
for
the
purpose
12


of
dispensing
medical
cannabidiol
in
this
state
pursuant
to
13


this
chapter.
14


9.
“Medical
cannabidiol
manufacturer”
means
an
entity
15


licensed
by
the
department
to
manufacture
and
to
possess,
16


cultivate,
transport,
or
supply
medical
cannabidiol
pursuant
to
17


the
provisions
of
this
chapter.
18


10.
“Primary
caregiver”
means
a
person,
at
least
eighteen
19


years
of
age,
who
has
legal
custody
of
the
patient
and
who
has
20


been
designated
by
a
patient’s
health
care
practitioner
as
a
21


necessary
caretaker
taking
responsibility
for
managing
the
22


well-being
of
the
patient
with
respect
to
the
use
of
medical
23


cannabidiol
pursuant
to
the
provisions
of
this
chapter.
24


11.
“Written
certification”
means
a
document
signed
by
a
25


health
care
practitioner,
with
whom
the
patient
has
established
26


a
patient-provider
relationship,
which
states
that
the
patient
27


has
a
debilitating
medical
condition
and
identifies
that
28


condition
and
provides
any
other
relevant
information.
29


Sec.
7.
NEW
SECTION


.
124E.3
Health
care
practitioner
30


certification
——
duties.
31


1.
Prior
to
a
patient’s
submission
of
an
application
for
a
32


medical
cannabidiol
card
pursuant
to
section
124E.4,
a
health
33


care
practitioner
shall
do
all
of
the
following:
34


a.
Determine,
in
the
health
care
practitioner’s
medical
35


-4-


LSB
6011YC
(3)
86


rh/rj


4/
25




H.F.
_____


judgment,
whether
the
patient
whom
the
health
care
practitioner
1


has
examined
and
treated
suffers
from
a
debilitating
medical
2


condition
that
qualifies
for
the
use
of
medical
cannabidiol
3


under
this
chapter,
and
if
so
determined,
provide
the
patient
4


with
a
written
certification
of
that
diagnosis.
5


b.
Provide
explanatory
information
as
provided
by
the
6


department
to
the
patient
about
the
therapeutic
use
of
medical
7


cannabidiol.
8


2.
Subsequently,
the
health
care
practitioner
shall
do
the
9


following:
10


a.
Determine,
on
an
annual
basis,
if
the
patient
continues
11


to
suffer
from
a
debilitating
medical
condition
and,
if
so,
12


issue
the
patient
a
new
certification
of
that
diagnosis.
13


b.
Otherwise
comply
with
all
requirements
established
by
the
14


department
pursuant
to
rule.
15


3.
A
health
care
practitioner
may
provide,
but
has
no
duty
16


to
provide,
a
written
certification
pursuant
to
this
section.
17


Sec.
8.
NEW
SECTION


.
124E.4
Medical
cannabidiol
18


registration
card.
19


1.
Issuance
to
patient.
The
department
may
approve
the
20


issuance
of
a
medical
cannabidiol
registration
card
by
the
21


department
of
transportation
to
a
patient
who:
22


a.
Is
at
least
eighteen
years
of
age.
23


b.
Is
a
permanent
resident
of
this
state.
24


c.
Submits
a
written
certification
to
the
department
signed
25


by
the
patient’s
health
care
practitioner
that
the
patient
is
26


suffering
from
a
debilitating
medical
condition.
27


d.
Submits
an
application
to
the
department,
on
a
form
28


created
by
the
department,
in
consultation
with
the
department
29


of
transportation,
that
contains
all
of
the
following:
30


(1)
The
patient’s
full
name,
Iowa
residence
address,
date
31


of
birth,
and
telephone
number.
32


(2)
A
copy
of
the
patient’s
valid
photograph
33


identification.


34


(3)
Full
name,
address,
and
telephone
number
of
the
35


-5-


LSB
6011YC
(3)
86


rh/rj


5/
25




H.F.
_____


patient’s
health
care
practitioner.
1


(4)
Full
name,
residence
address,
date
of
birth,
and
2


telephone
number
of
each
primary
caregiver
of
the
patient,
if
3


any.
4


(5)
Any
other
information
required
by
rule.
5


e.
Submits
a
medical
cannabidiol
registration
card
fee
of
6


one
hundred
dollars
to
the
department.
If
the
patient
attests
7


to
receiving
social
security
disability
benefits,
supplemental
8


security
insurance
payments,
or
being
enrolled
in
the
medical
9


assistance
program,
the
fee
shall
be
twenty-five
dollars.
10


2.
Patient
card
contents.
A
medical
cannabidiol
11


registration
card
issued
to
a
patient
by
the
department
of
12


transportation
pursuant
to
subsection
1
shall
contain,
at
a
13


minimum,
all
of
the
following:
14


a.
The
patient’s
full
name,
Iowa
residence
address,
and
date
15


of
birth.
16


b.
The
patient’s
photograph.
17


c.
The
date
of
issuance
and
expiration
date
of
the
18


registration
card.
19


d.
Any
other
information
required
by
rule.
20


3.
Issuance
to
primary
caregiver.
For
a
patient
in
a
21


primary
caregiver’s
care,
the
department
may
approve
the
22


issuance
of
a
medical
cannabidiol
registration
card
by
the
23


department
of
transportation
to
the
primary
caregiver
who:
24


a.
Is
at
least
eighteen
years
of
age.
25


b.
Submits
a
written
certification
to
the
department
signed
26


by
the
patient’s
health
care
practitioner
that
the
patient
in
27


the
primary
caregiver’s
care
is
suffering
from
a
debilitating
28


medical
condition.


29


c.
Submits
an
application
to
the
department,
on
a
form
30


created
by
the
department,
in
consultation
with
the
department
31


of
transportation,
that
contains
all
of
the
following:
32


(1)
The
primary
caregiver’s
full
name,
residence
address,
33


date
of
birth,
and
telephone
number.
34


(2)
The
patient’s
full
name.
35


-6-


LSB
6011YC
(3)
86


rh/rj


6/
25



H.F.
_____


(3)
A
copy
of
the
primary
caregiver’s
valid
photograph
1


identification.
2


(4)
Full
name,
address,
and
telephone
number
of
the
3


patient’s
health
care
practitioner.
4


(5)
Any
other
information
required
by
rule.
5


d.
Submits
a
medical
cannabidiol
registration
card
fee
of
6


twenty-five
dollars
to
the
department.
7


4.
Primary
caregiver
card
contents.
A
medical
cannabidiol
8


registration
card
issued
by
the
department
of
transportation
to
9


a
primary
caregiver
pursuant
to
subsection
3
shall
contain,
at
10


a
minimum,
all
of
the
following:
11


a.
The
primary
caregiver’s
full
name,
residence
address,
and
12


date
of
birth.
13


b.
The
primary
caregiver’s
photograph.
14


c.
The
date
of
issuance
and
expiration
date
of
the
15


registration
card.
16


d.
The
registration
card
number
of
each
patient
in
the
17


primary
caregiver’s
care.
If
the
patient
in
the
primary
18


caregiver’s
care
is
under
the
age
of
eighteen,
the
full
name
of
19


the
patient’s
parent
or
legal
guardian.
20


e.
Any
other
information
required
by
rule.
21


5.
Expiration
date
of
card.
A
medical
cannabidiol
22


registration
card
issued
pursuant
to
this
section
shall
expire
23


one
year
after
the
date
of
issuance
and
may
be
renewed.
24


6.
Card
issuance
——
department
of
transportation.
The
25


department
may
enter
into
a
chapter
28E
agreement
with
the
26


department
of
transportation
to
facilitate
the
issuance
of
27


medical
cannabidiol
registration
cards
pursuant
to
subsections
28


1
and
3.
29


Sec.
9.
NEW
SECTION


.
124E.5
Medical
advisory
board
——
30


duties.
31


1.
No
later
than
August
15,
2016,
the
director
of
public
32


health
shall
establish
a
medical
advisory
board
consisting
of
33


nine
practitioners
representing
the
fields
of
neurology,
pain
34


management,
gastroenterology,
oncology,
psychiatry,
pediatrics,
35


-7-


LSB
6011YC
(3)
86


rh/rj


7/
25




H.F.
_____


infectious
disease,
family
medicine,
and
pharmacy,
and
three
1


patients
with
valid
medical
cannabidiol
registration
cards.
2


The
practitioners
shall
be
nationally
board-certified
in
their
3


area
of
specialty
and
knowledgeable
about
the
use
of
medical
4


cannabidiol.
5


2.
A
quorum
of
the
advisory
board
shall
consist
of
seven
6


members.
7


3.
The
duties
of
the
advisory
board
shall
include
but
not
be
8


limited
to
the
following:
9


a.
Reviewing
and
recommending
to
the
department
for
10


approval
additional
chronic
or
debilitating
diseases
or
11


medical
conditions
or
their
treatments
as
debilitating
medical
12


conditions
that
qualify
for
the
use
of
medical
cannabidiol
13


under
this
chapter.
14


b.
Accepting
and
reviewing
petitions
to
add
chronic
or
15


debilitating
diseases
or
medical
conditions
or
their
medical
16


treatments
to
the
list
of
debilitating
medical
conditions
that
17


qualify
for
the
use
of
medical
cannabidiol
under
this
chapter.
18


c.
Advising
the
department
regarding
the
location
of
medical
19


cannabidiol
dispensaries
throughout
the
state,
the
form
and
20


quantity
of
allowable
medical
cannabidiol
to
be
dispensed
to
21


a
patient
or
primary
caregiver,
and
the
general
oversight
of
22


medical
cannabidiol
manufacturers
and
medical
cannabidiol
23


dispensaries
in
this
state.
24


d.
Convening
at
least
twice
per
year
to
conduct
public
25


hearings
and
to
evaluate
petitions,
which
shall
be
maintained
26


as
confidential
personal
health
information,
to
add
chronic
or
27


debilitating
diseases
or
medical
conditions
or
their
medical
28


treatments
to
the
list
of
debilitating
medical
conditions
that
29


qualify
for
the
use
of
medical
cannabidiol
under
this
chapter.
30


Sec.
10.
NEW
SECTION


.
124E.6
Medical
cannabidiol
31


manufacturer
licensure.


32


1.
a.
The
department
shall
license
four
medical
cannabidiol
33


manufacturers
by
December
1,
2016,
to
manufacture
medical
34


cannabidiol
within
this
state
consistent
with
the
provisions
35


-8-


LSB
6011YC
(3)
86


rh/rj


8/
25




H.F.
_____


of
this
chapter.
The
department
shall
license
new
medical
1


cannabidiol
manufacturers
or
relicense
the
existing
medical
2


cannabidiol
manufacturers
by
December
1
of
each
year.
3


b.
Information
submitted
during
the
application
process
4


shall
be
confidential
until
the
medical
cannabidiol
5


manufacturer
is
licensed
by
the
department
unless
otherwise
6


protected
from
disclosure
under
state
or
federal
law.
7


2.
As
a
condition
for
licensure,
a
medical
cannabidiol
8


manufacturer
must
agree
to
begin
supplying
medical
cannabidiol
9


to
medical
cannabidiol
dispensaries
in
this
state
by
July
1,
10


2017.
11


3.
The
department
shall
consider
the
following
factors
12


in
determining
whether
to
license
a
medical
cannabidiol
13


manufacturer:
14


a.
The
technical
expertise
of
the
medical
cannabidiol
15


manufacturer
in
medical
cannabidiol.
16


b.
The
qualifications
of
the
medical
cannabidiol
17


manufacturer’s
employees.
18


c.
The
long-term
financial
stability
of
the
medical
19


cannabidiol
manufacturer.
20


d.
The
ability
to
provide
appropriate
security
measures
on
21


the
premises
of
the
medical
cannabidiol
manufacturer.
22


e.
Whether
the
medical
cannabidiol
manufacturer
has
23


demonstrated
an
ability
to
meet
certain
medical
cannabidiol
24


production
needs
for
medical
use
regarding
the
range
of
25


recommended
dosages
for
each
debilitating
medical
condition,
26


the
range
of
chemical
compositions
of
any
plant
of
the
genus
27


Cannabis
that
will
likely
be
medically
beneficial
for
each
28


of
the
debilitating
medical
conditions,
and
the
form
of
the
29


medical
cannabidiol
in
the
manner
determined
by
the
department
30


pursuant
to
rule.
31


f.
The
medical
cannabidiol
manufacturer’s
projection
of
32


and
ongoing
assessment
of
fees
on
patients
with
debilitating
33


medical
conditions.
34


4.
The
department
shall
require
each
medical
cannabidiol
35


-9-


LSB
6011YC
(3)
86


rh/rj


9/
25



H.F.
_____


manufacturer
to
contract
with
the
state
hygienic
laboratory
1


at
the
university
of
Iowa
in
Iowa
City
to
test
the
medical
2


cannabidiol
produced
by
the
manufacturer
as
to
content,
3


contamination,
and
consistency.
The
department
shall
require
4


that
the
laboratory
report
testing
results
to
the
manufacturer
5


in
a
manner
determined
by
the
department
pursuant
to
rule.
6


5.
Each
entity
submitting
an
application
for
licensure
as
7


a
medical
cannabidiol
manufacturer
shall
pay
a
nonrefundable
8


application
fee
of
ten
thousand
dollars
to
the
department.
9


Sec.
11.
NEW
SECTION


.
124E.7
Medical
cannabidiol
10


manufacturers.
11


1.
A
medical
cannabidiol
manufacturer
shall
pay
the
cost
of
12


all
laboratory
testing.
13


2.
The
operating
documents
of
a
medical
cannabidiol
14


manufacturer
shall
include
all
of
the
following:
15


a.
Procedures
for
the
oversight
of
the
medical
cannabidiol
16


manufacturer
and
procedures
to
ensure
accurate
record
keeping.
17


b.
Procedures
for
the
implementation
of
appropriate
security
18


measures
to
deter
and
prevent
the
theft
of
medical
cannabidiol
19


and
unauthorized
entrance
into
areas
containing
medical
20


cannabidiol.
21


3.
A
medical
cannabidiol
manufacturer
shall
implement
22


security
requirements,
including
requirements
for
protection
23


of
each
location
by
a
fully
operational
security
alarm
system,
24


facility
access
controls,
perimeter
intrusion
detection
25


systems,
and
a
personnel
identification
system.
26


4.
A
medical
cannabidiol
manufacturer
shall
not
share


27


office
space
with,
refer
patients
to,
or
have
any
financial
28


relationship
with
a
health
care
practitioner.
29


5.
A
medical
cannabidiol
manufacturer
shall
not
permit
any
30


person
to
consume
medical
cannabidiol
on
the
property
of
the
31


medical
cannabidiol
manufacturer.
32


6.
A
medical
cannabidiol
manufacturer
is
subject
to
33


reasonable
inspection
by
the
department.
34


7.
A
medical
cannabidiol
manufacturer
shall
not
employ
35


-10-


LSB
6011YC
(3)
86


rh/rj


10/
25




H.F.
_____


a
person
who
is
under
eighteen
years
of
age
or
who
has
been
1


convicted
of
a
disqualifying
felony
offense.
An
employee
2


of
a
medical
cannabidiol
manufacturer
shall
be
subject
to
a
3


background
investigation
conducted
by
the
division
of
criminal
4


investigation
of
the
department
of
public
safety
and
a
national
5


criminal
history
background
check.
6


8.
A
medical
cannabidiol
manufacturer
shall
not
operate
7


in
any
location,
whether
for
manufacturing,
cultivating,
8


harvesting,
packaging,
or
processing,
within
one
thousand
feet
9


of
a
public
or
private
school
existing
before
the
date
of
the
10


medical
cannabidiol
manufacturer’s
licensure
by
the
department.
11


9.
A
medical
cannabidiol
manufacturer
shall
comply
with
12


reasonable
restrictions
set
by
the
department
relating
to
13


signage,
marketing,
display,
and
advertising
of
medical
14


cannabidiol.
15


10.
a.
A
medical
cannabidiol
manufacturer
shall
provide
a
16


reliable
and
ongoing
supply
of
medical
cannabidiol
to
medical
17


cannabidiol
dispensaries
pursuant
to
this
chapter.
18


b.
All
manufacturing,
cultivating,
harvesting,
packaging,
19


and
processing
of
medical
cannabidiol
shall
take
place
in
an
20


enclosed,
locked
facility
at
a
physical
address
provided
to
the
21


department
during
the
licensure
process.
22


c.
A
medical
cannabidiol
manufacturer
shall
not
manufacture
23


edible
medical
cannabidiol
products
utilizing
food
coloring.
24


d.
A
medical
cannabidiol
manufacturer
shall
manufacture
a
25


reliable
and
ongoing
supply
of
medical
cannabidiol
to
treat
26


every
debilitating
medical
condition
listed
in
this
chapter.
27


11.
A
medical
cannabidiol
manufacturer
shall
pay
an
28


annual
fee
determined
by
the
department
equal
to
the
cost
of
29


regulating
and
inspecting
the
manufacturer
during
that
year.
30


Sec.
12.
NEW
SECTION


.
124E.8
Medical
cannabidiol
dispensary
31


licensure.


32


1.
a.
The
department
shall
license
by
April
1,
2017,
33


twelve
medical
cannabidiol
dispensaries
to
dispense
medical
34


cannabidiol
within
this
state
consistent
with
the
provisions
35


-11-


LSB
6011YC
(3)
86


rh/rj


11/
25




H.F.
_____


of
this
chapter.
The
department
shall
license
new
medical
1


cannabidiol
dispensaries
or
relicense
the
existing
medical
2


cannabidiol
manufacturers
by
December
1
of
each
year.
3


b.
Information
submitted
during
the
application
process
4


shall
be
confidential
until
the
medical
cannabidiol
dispensary
5


is
licensed
by
the
department
unless
otherwise
protected
from
6


disclosure
under
state
or
federal
law.
7


2.
As
a
condition
for
licensure,
a
medical
cannabidiol
8


dispensary
must
agree
to
begin
supplying
medical
cannabidiol
to
9


patients
by
July
1,
2017.
10


3.
The
department
shall
consider
the
following
factors
11


in
determining
whether
to
license
a
medical
cannabidiol
12


dispensary:
13


a.
The
technical
expertise
of
the
medical
cannabidiol
14


dispensary
regarding
medical
cannabidiol.
15


b.
The
qualifications
of
the
medical
cannabidiol
16


dispensary’s
employees.
17


c.
The
long-term
financial
stability
of
the
medical
18


cannabidiol
dispensary.
19


d.
The
ability
to
provide
appropriate
security
measures
on
20


the
premises
of
the
medical
cannabidiol
dispensary.
21


e.
The
medical
cannabidiol
dispensary’s
projection
and
22


ongoing
assessment
of
fees
for
the
purchase
of
medical
23


cannabidiol
on
patients
with
debilitating
medical
conditions.
24


4.
Each
entity
submitting
an
application
for
licensure
as
25


a
medical
cannabidiol
dispensary
shall
pay
a
nonrefundable
26


application
fee
of
ten
thousand
dollars
to
the
department.
27


5.
A
medical
cannabidiol
dispensary
shall
pay
an
annual
fee
28


determined
by
the
department
equal
to
the
cost
of
regulating
29


and
inspecting
the
manufacturer
during
that
year.
30


Sec.
13.
NEW
SECTION


.
124E.9
Medical
cannabidiol
31


dispensaries.
32


1.
a.
The
medical
cannabidiol
dispensaries
shall
be
located
33


based
on
geographical
need
throughout
the
state
to
improve
34


patient
access.
35


-12-


LSB
6011YC
(3)
86


rh/rj


12/
25




H.F.
_____


b.
A
medical
cannabidiol
dispensary
may
dispense
medical
1


cannabidiol
pursuant
to
the
provisions
of
this
chapter
but
2


shall
not
dispense
any
medical
cannabidiol
in
a
form
or
3


quantity
other
than
the
form
or
quantity
allowed
by
the
4


department
pursuant
to
rule.
5


2.
The
operating
documents
of
a
medical
cannabidiol
6


dispensary
shall
include
all
of
the
following:
7


a.
Procedures
for
the
oversight
of
the
medical
cannabidiol
8


dispensary
and
procedures
to
ensure
accurate
record
keeping.
9


b.
Procedures
for
the
implementation
of
appropriate
security
10


measures
to
deter
and
prevent
the
theft
of
medical
cannabidiol
11


and
unauthorized
entrance
into
areas
containing
medical
12


cannabidiol.
13


3.
A
medical
cannabidiol
dispensary
shall
implement
14


security
requirements,
including
requirements
for
protection
15


by
a
fully
operational
security
alarm
system,
facility
16


access
controls,
perimeter
intrusion
detection
systems,
and
a
17


personnel
identification
system.
18


4.
A
medical
cannabidiol
dispensary
shall
not
share
19


office
space
with,
refer
patients
to,
or
have
any
financial
20


relationship
with
a
health
care
practitioner.
21


5.
A
medical
cannabidiol
dispensary
shall
not
permit
any
22


person
to
consume
medical
cannabidiol
on
the
property
of
the
23


medical
cannabidiol
dispensary.
24


6.
A
medical
cannabidiol
dispensary
is
subject
to
25


reasonable
inspection
by
the
department.
26


7.
A
medical
cannabidiol
dispensary
shall
not
employ
a
27


person
who
is
under
eighteen
years
of
age
or
who
has
been
28


convicted
of
a
disqualifying
felony
offense.
An
employee
29


of
a
medical
cannabidiol
dispensary
shall
be
subject
to
a
30


background
investigation
conducted
by
the
division
of
criminal
31


investigation
of
the
department
of
public
safety
and
a
national
32


criminal
history
background
check.
33


8.
A
medical
cannabidiol
dispensary
shall
not
operate
in
34


any
location
within
one
thousand
feet
of
a
public
or
private
35


-13-


LSB
6011YC
(3)
86


rh/rj


13/
25



H.F.
_____


school
existing
before
the
date
of
the
medical
cannabidiol
1


dispensary’s
licensure
by
the
department.
2


9.
A
medical
cannabidiol
dispensary
shall
comply
with
3


reasonable
restrictions
set
by
the
department
relating
to
4


signage,
marketing,
display,
and
advertising
of
medical
5


cannabidiol.
6


10.
Prior
to
dispensing
of
any
medical
cannabidiol,
a
7


medical
cannabidiol
dispensary
shall
do
all
of
the
following:
8


a.
Verify
that
the
medical
cannabidiol
dispensary
has
9


received
a
valid
medical
cannabidiol
registration
card
from
a
10


patient
or
a
patient’s
primary
caregiver,
if
applicable.
11


b.
Assign
a
tracking
number
to
any
medical
cannabidiol
12


dispensed
from
the
medical
cannabidiol
dispensary.
13


c.
(1)
Properly
package
medical
cannabidiol
in
compliance
14


with
federal
law
regarding
child
resistant
packaging
and
15


exemptions
for
packaging
for
elderly
patients,
and
label
16


medical
cannabidiol
with
a
list
of
all
active
ingredients
and
17


individually
identifying
information,
including
all
of
the
18


following:
19


(a)
The
name
and
date
of
birth
of
the
patient
and
the
20


patient’s
primary
caregiver,
if
appropriate.
21


(b)
The
medical
cannabidiol
registration
card
numbers
22


of
the
patient
and
of
the
patient’s
primary
caregiver,
if
23


applicable.
24


(c)
The
chemical
composition
of
the
medical
cannabidiol.
25


(2)
Proper
packaging
of
medical
cannabidiol
shall
include
26


but
not
be
limited
to
all
of
the
following:
27


(a)
Warning
labels
regarding
the
use
of
medical
cannabidiol
28


by
a
woman
during
pregnancy
and
while
breastfeeding.
29


(b)
Clearly
labeled
packaging
indicating
that
an
edible
30


medical
cannabidiol
product
contains
medical
cannabidiol,
which
31


packaging
shall
not
imitate
candy
products
or
in
any
way
make
32


the
product
marketable
to
children.
33


11.
A
medical
cannabidiol
dispensary
shall
employ
a
34


pharmacist
licensed
pursuant
to
chapter
155A.
35


-14-


LSB
6011YC
(3)
86


rh/rj


14/
25



H.F.
_____


Sec.
14.
NEW
SECTION
.
124E.10
Fees.
1


Medical
cannabidiol
registration
card
fees
and
medical
2


cannabidiol
manufacturer
and
medical
cannabidiol
dispensary
3


application
and
annual
fees
collected
by
the
department
4


pursuant
to
this
chapter
shall
be
retained
by
the
department,
5


shall
be
considered
repayment
receipts
as
defined
in
section
6


8.2,
and
shall
be
used
for
the
purpose
of
regulating
medical
7


cannabidiol
manufacturers
and
medical
cannabidiol
dispensaries
8


and
for
other
expenses
necessary
for
the
administration
of
this
9


chapter.
10


Sec.
15.
NEW
SECTION


.
124E.11
Department
duties
——
rules.
11


1.
a.
The
department
shall
maintain
a
confidential
file
12


of
the
names
of
each
patient
to
or
for
whom
the
department
13


issues
a
medical
cannabidiol
registration
card
and
the
name
of
14


each
primary
caregiver
to
whom
the
department
issues
a
medical
15


cannabidiol
registration
card
under
section
124E.4.
16


b.
Individual
names
contained
in
the
file
shall
be
17


confidential
and
shall
not
be
subject
to
disclosure,
except
as
18


provided
in
subparagraph
(1).
19


(1)
Information
in
the
confidential
file
maintained
20


pursuant
to
paragraph
“a”
may
be
released
on
an
individual
basis
21


to
the
following
persons
under
the
following
circumstances:
22


(a)
To
authorized
employees
or
agents
of
the
department
and
23


the
department
of
transportation
as
necessary
to
perform
the
24


duties
of
the
department
and
the
department
of
transportation
25


pursuant
to
this
chapter.
26


(b)
To
authorized
employees
of
state
or
local
law
27


enforcement
agencies,
but
only
for
the
purpose
of
verifying
28


that
a
person
is
lawfully
in
possession
of
a
medical
29


cannabidiol
registration
card
issued
pursuant
to
this
chapter.
30


(c)
To
authorized
employees
of
a
medical
cannabidiol
31


dispensary,
but
only
for
the
purpose
of
verifying
that
a
person
32


is
lawfully
in
possession
of
a
medical
cannabidiol
registration
33


card
issued
pursuant
to
this
chapter.
34


(2)
Release
of
information
pursuant
to
subparagraph
35


-15-


LSB
6011YC
(3)
86


rh/rj


15/
25





H.F.
_____


(1)
shall
be
consistent
with
the
federal
Health
Insurance
1


Portability
and
Accountability
Act
of
1996,
Pub.
L.
No.
2


104-191.
3


2.
The
department
shall
adopt
rules
pursuant
to
chapter
4


17A
to
administer
this
chapter
which
shall
include
but
not
be
5


limited
to
rules
to
do
all
of
the
following:
6


a.
Govern
the
manner
in
which
the
department
shall
7


consider
applications
for
new
and
renewal
medical
cannabidiol
8


registration
cards.
9


b.
Identify
criteria
and
set
forth
procedures
for
10


including
additional
chronic
or
debilitating
diseases
or
11


medical
conditions
or
their
medical
treatments
on
the
list
12


of
debilitating
medical
conditions
that
qualify
for
the
use
13


of
medical
cannabidiol.
Procedures
shall
include
a
petition
14


process
and
shall
allow
for
public
comment
and
public
hearings
15


before
the
medical
advisory
board.
16


c.
Set
forth
additional
chronic
or
debilitating
diseases
or
17


medical
conditions
or
their
medical
treatments
for
inclusion
on
18


the
list
of
debilitating
medical
conditions
that
qualify
for
19


the
use
of
medical
cannabidiol
as
recommended
by
the
medical
20


advisory
board.
21


d.
Establish
the
form
and
quantity
of
medical
cannabidiol
22


allowed
to
be
dispensed
to
a
patient
or
primary
caregiver
23


pursuant
to
this
chapter.
The
form
and
quantity
of
medical
24


cannabidiol
shall
be
appropriate
to
serve
the
medical
needs
of
25


patients
with
debilitating
medical
conditions.
26


e.
Establish
requirements
for
the
licensure
of
medical
27


cannabidiol
manufacturers
and
medical
cannabidiol
dispensaries
28


and
set
forth
procedures
for
medical
cannabidiol
manufacturers
29


and
medical
cannabidiol
dispensaries
to
obtain
licenses.
30


f.
Develop
a
dispensing
system
for
medical
cannabidiol
31


within
this
state
that
provides
for
all
of
the
following:
32


(1)
Medical
cannabidiol
dispensaries
within
this
state
33


housed
on
secured
grounds
and
operated
by
medical
cannabidiol
34


dispensaries.
35


-16-


LSB
6011YC
(3)
86


rh/rj


16/
25



H.F.
_____


(2)
The
dispensing
of
medical
cannabidiol
to
patients
and
1


their
primary
caregivers
to
occur
at
locations
designated
by
2


the
department.
3


g.
Establish
and
collect
annual
fees
from
medical
4


cannabidiol
manufacturers
and
medical
cannabidiol
dispensaries
5


to
cover
the
costs
associated
with
regulating
and
inspecting
6


medical
cannabidiol
manufacturers
and
medical
cannabidiol
7


dispensaries.
8


h.
Specify
and
implement
procedures
that
address
public
9


safety
including
security
procedures
and
product
quality
10


including
measures
to
ensure
contaminant-free
cultivation
of
11


medical
cannabidiol,
safety,
and
appropriate
labeling.
12


i.
Establish
and
implement
a
real-time,
statewide
13


medical
cannabidiol
registry
management
sale
tracking
system
14


that
is
available
to
medical
cannabidiol
dispensaries
on
a
15


twenty-four-hour-day,
seven-day-a-week
basis
for
the
purpose
of
16


verifying
that
a
person
is
lawfully
in
possession
of
a
medical
17


cannabidiol
registration
card
issued
pursuant
to
this
chapter
18


and
for
tracking
the
date
of
the
sale
and
quantity
of
medical
19


cannabidiol
purchased
by
a
patient
or
a
primary
caregiver.
20


j.
Establish
and
implement
a
medical
cannabidiol
inventory
21


and
delivery
tracking
system
to
track
medical
cannabidiol
22


from
production
by
a
medical
cannabidiol
manufacturer
through
23


dispensing
at
a
medical
cannabidiol
dispensary.
24


Sec.
16.
NEW
SECTION


.
124E.12
Reciprocity.
25


A
valid
medical
cannabidiol
registration
card,
or
its
26


equivalent,
issued
under
the
laws
of
another
state
that
allows
27


an
out-of-state
patient
to
possess
or
use
medical
cannabidiol
28


in
the
jurisdiction
of
issuance
shall
have
the
same
force
and
29


effect
as
a
valid
medical
cannabidiol
registration
card
issued
30


pursuant
to
this
chapter,
except
that
an
out-of-state
patient
31


in
this
state
shall
not
obtain
medical
cannabidiol
from
a


32


medical
cannabidiol
dispensary
in
this
state.
33


Sec.
17.
NEW
SECTION


.
124E.13
Use
of
medical
cannabidiol
——
34


smoking
prohibited.
35


-17-


LSB
6011YC
(3)
86


rh/rj


17/
25





H.F.
_____


A
patient,
including
an
out-of-state
patient
who
is
in
Iowa,
1


shall
not
consume
medical
cannabidiol
possessed
or
used
as
2


authorized
by
this
chapter
by
smoking
medical
cannabidiol.
3


Sec.
18.
NEW
SECTION


.
124E.14
Use
of
medical
cannabidiol
4


——
affirmative
defenses.
5


1.
A
health
care
practitioner,
including
any
authorized
6


agent
or
employee
thereof,
shall
not
be
subject
to
7


prosecution
for
the
unlawful
certification,
possession,
or
8


administration
of
marijuana
under
the
laws
of
this
state
for
9


activities
arising
directly
out
of
or
directly
related
to
the
10


certification
or
use
of
medical
cannabidiol
in
the
treatment
11


of
a
patient
diagnosed
with
a
debilitating
medical
condition
12


as
authorized
by
this
chapter.
13


2.
A
medical
cannabidiol
manufacturer,
including
any
14


authorized
agent
or
employee
thereof,
shall
not
be
subject
15


to
prosecution
for
manufacturing,
possessing,
cultivating,
16


harvesting,
packaging,
processing,
transporting,
or
supplying
17


medical
cannabidiol
pursuant
to
this
chapter.
18


3.
A
medical
cannabidiol
dispensary,
including
any
19


authorized
agent
or
employee
thereof,
shall
not
be
subject
to
20


prosecution
for
transporting,
supplying,
or
dispensing
medical
21


cannabidiol
pursuant
to
this
chapter.
22


4.
a.
In
a
prosecution
for
the
unlawful
possession
of
23


marijuana
under
the
laws
of
this
state,
including
but
not
24


limited
to
chapters
124
and
453B,
it
is
an
affirmative
and
25


complete
defense
to
the
prosecution
that
the
patient
has
been
26


diagnosed
with
a
debilitating
medical
condition,
used
or
27


possessed
medical
cannabidiol
pursuant
to
a
certification
by
a
28


health
care
practitioner
as
authorized
under
this
chapter,
and,
29


for
a
patient
eighteen
years
of
age
or
older,
is
in
possession
30


of
a
valid
medical
cannabidiol
registration
card.
31


b.
In
a
prosecution
for
the
unlawful
possession
of
marijuana
32


under
the
laws
of
this
state,
including
but
not
limited
to
33


chapters
124
and
453B,
it
is
an
affirmative
and
complete
34


defense
to
the
prosecution
that
the
person
possessed
medical
35


-18-


LSB
6011YC
(3)
86


rh/rj


18/
25




H.F.
_____


cannabidiol
because
the
person
is
a
primary
caregiver
of
a
1


patient
who
has
been
diagnosed
with
a
debilitating
medical
2


condition
and
is
in
possession
of
a
valid
medical
cannabidiol
3


registration
card,
and
where
the
primary
caregiver’s
possession
4


of
the
medical
cannabidiol
is
on
behalf
of
the
patient
and
for
5


the
patient’s
use
only
as
authorized
under
this
chapter.
6


c.
If
a
patient
or
primary
caregiver
is
charged
with
the
7


commission
of
a
crime
and
is
not
in
possession
of
the
person’s
8


medical
cannabidiol
registration
card,
any
charge
or
charges
9


filed
against
the
person
shall
be
dismissed
by
the
court
if
the
10


person
produces
to
the
court
prior
to
or
at
the
person’s
trial
11


a
medical
cannabidiol
registration
card
issued
to
that
person
12


and
valid
at
the
time
the
person
was
charged.
13


5.
An
agency
of
this
state
or
a
political
subdivision
14


thereof,
including
any
law
enforcement
agency,
shall
not
remove
15


or
initiate
proceedings
to
remove
a
patient
under
the
age
16


of
eighteen
from
the
home
of
a
parent
based
solely
upon
the
17


parent’s
or
patient’s
possession
or
use
of
medical
cannabidiol
18


as
authorized
under
this
chapter.
19


Sec.
19.
NEW
SECTION


.
124E.15
Penalties.
20


1.
A
person
who
knowingly
or
intentionally
possesses
or
uses
21


medical
cannabidiol
in
violation
of
the
requirements
of
this
22


chapter
is
subject
to
the
penalties
provided
under
chapters
124
23


and
453B.
24


2.
A
medical
cannabidiol
manufacturer
or
a
medical
25


cannabidiol
dispensary
shall
be
assessed
a
civil
penalty
of
up
26


to
one
thousand
dollars
per
violation
for
any
violation
of
this
27


chapter
in
addition
to
any
other
applicable
penalties.
28


Sec.
20.
TRANSITION
PROVISIONS.
A
medical
cannabidiol
29


registration
card
issued
under
chapter
124D
prior
to
July
1,
30


2016,
remains
effective
and
continues
in
effect
as
issued
for
31


the
twelve-month
period
following
its
issuance.
This
Act
does
32


not
preclude
the
permit
holder
from
seeking
to
renew
the
permit
33


under
this
Act
prior
to
the
expiration
of
the
twelve-month
34


period.
35


-19-


LSB
6011YC
(3)
86


rh/rj


19/
25




H.F.
_____


Sec.
21.
REPEAL.
Chapter
124D,
Code
2016,
is
repealed.
1


Sec.
22.
EFFECTIVE
UPON
ENACTMENT.
This
Act,
being
deemed
2


of
immediate
importance,
takes
effect
upon
enactment.
3


EXPLANATION
4


The
inclusion
of
this
explanation
does
not
constitute
agreement
with
5


the
explanation’s
substance
by
the
members
of
the
general
assembly.
6


This
bill
creates
the
medical
cannabidiol
Act
and
provides
7


for
civil
and
criminal
penalties
and
fees.
8


RECLASSIFICATION
——
MARIJUANA.
The
bill
reclassifies
9


marijuana,
including
tetrahydrocannabinols,
as
a
schedule
10


II
controlled
substance
instead
of
a
schedule
I
controlled
11


substance
and
strikes
references
to
the
authority
of
the
12


board
of
pharmacy
to
adopt
rules
for
the
use
of
marijuana
or
13


tetrahydrocannabinols
for
medicinal
purposes.
14


MEDICAL
CANNABIDIOL
ACT
OVERVIEW.
The
bill
provides
15


that
a
patient
with
a
debilitating
medical
condition,
who
16


receives
written
certification
from
the
patient’s
health
care
17


practitioner
that
the
patient
has
a
debilitating
medical
18


condition
and
who
submits
the
written
certification
along
with
19


an
application
to
the
department
of
public
health
(department)
20


for
a
medical
cannabidiol
registration
card,
may
lawfully
use
21


medical
cannabidiol
to
treat
the
patient’s
debilitating
medical
22


condition.
A
patient
who
is
issued
a
medical
cannabidiol
23


registration
card
will
be
able
to
receive
medical
cannabidiol
24


directly
from
a
licensed
medical
cannabidiol
dispensary
in
this
25


state.
The
bill
defines
“debilitating
medical
conditions”,
26


“health
care
practitioner”,
“medical
cannabidiol”,
and
other
27


terms.


28


HEALTH
CARE
PRACTITIONER
CERTIFICATION.
The
bill
provides
29


that
prior
to
a
patient’s
submission
of
an
application
for
30


a
medical
cannabidiol
registration
card,
if
a
health
care
31


practitioner
determines
that
the
patient
whom
the
health
32


care
practitioner
has
examined
and
treated
suffers
from
a
33


debilitating
medical
condition,
the
health
care
practitioner
34


may
provide
the
patient
with
a
written
certification
of
that
35


-20-


LSB
6011YC
(3)
86


rh/rj


20/
25



H.F.
_____


diagnosis.
If
the
health
care
practitioner
provides
the
1


written
certification,
the
practitioner
must
also
provide
2


explanatory
information
to
the
patient
about
the
therapeutic
3


use
of
medical
cannabidiol,
and
if
the
patient
continues
to
4


suffer
from
a
debilitating
medical
condition,
issue
the
patient
5


a
new
certification
of
that
diagnosis
on
an
annual
basis.
6


MEDICAL
CANNABIDIOL
REGISTRATION
CARD
——
PATIENT
AND
7


PRIMARY
CAREGIVER.
The
bill
provides
for
the
issuance
of
a
8


medical
cannabidiol
registration
card
by
the
department
of
9


transportation
to
a
patient
and
to
a
primary
caregiver
upon
10


submission
of
an
application
and
fee
to
the
department
of
11


public
health,
if
such
applications
meet
certain
requirements.
12


A
medical
cannabidiol
registration
card
expires
one
year
after
13


the
date
of
issuance
and
may
be
renewed.
14


MEDICAL
ADVISORY
BOARD.
The
director
of
public
health
is
15


required
to
establish
a
medical
advisory
board,
no
later
than
16


August
15,
2016,
to
consist
of
nine
practitioners
representing
17


the
fields
of
neurology,
pain
management,
gastroenterology,
18


oncology,
psychiatry,
pediatrics,
infectious
disease,
family
19


medicine,
and
pharmacy,
and
three
patients
with
valid
medical
20


cannabidiol
registration
cards.
The
bill
provides
for
the
21


duties
of
the
board,
including
making
recommendations
to
22


the
department
of
public
health
for
approval
of
additional
23


debilitating
medical
conditions
that
can
be
treated
with
24


medical
cannabidiol.
25


MEDICAL
CANNABIDIOL
MANUFACTURER
LICENSURE.
The
bill
26


requires
the
department
to
license
by
December
1,
2016,
four
27


medical
cannabidiol
manufacturers
for
the
manufacture
of


28


medical
cannabidiol
within
this
state
and
to
license
new


29


medical
cannabidiol
manufacturers
or
relicense
existing
30


medical
cannabidiol
manufacturers
by
December
1
of
each
31


year.
As
a
condition
for
licensure,
a
medical
cannabidiol
32


manufacturer
must
agree
to
begin
supplying
medical
cannabidiol
33


to
medical
cannabidiol
dispensaries
in
this
state
by
July
1,
34


2017.
The
department
is
directed
to
consider
several
factors
35


-21-


LSB
6011YC
(3)
86


rh/rj


21/
25



H.F.
_____


in
determining
whether
to
license
a
medical
cannabidiol
1


manufacturer.
Each
medical
cannabidiol
manufacturer
is
2


required
to
contract
with
the
state
hygienic
laboratory
at
the
3


university
of
Iowa
to
test
the
medical
cannabidiol
produced
4


by
the
manufacturer
and
to
report
testing
results
to
the
5


medical
cannabidiol
manufacturer,
and
is
required
to
pay
a
6


nonrefundable
application
fee
of
$10,000.
7


MEDICAL
CANNABIDIOL
MANUFACTURERS.
The
bill
provides
8


that
certain
requirements
must
be
included
in
the
operating
9


documents
of
a
medical
cannabidiol
manufacturer.
A
medical
10


cannabidiol
manufacturer
is
prohibited
from
engaging
in
11


certain
activities
and
is
subject
to
reasonable
inspection
and
12


reasonable
restrictions
by
the
department.
13


A
medical
cannabidiol
manufacturer
is
required
to
provide
a
14


reliable
and
ongoing
supply
of
medical
cannabidiol
to
medical
15


cannabidiol
dispensaries
and
to
treat
every
debilitating
16


medical
condition
pursuant
to
the
provisions
of
the
bill
and
17


manufacture,
cultivate,
harvest,
package,
and
process
medical
18


cannabidiol
in
an
enclosed,
locked
facility
at
a
physical
19


address
provided
to
the
department
during
the
licensure
20


process;
and
is
prohibited
from
manufacturing
edible
medical
21


cannabidiol
products
with
food
coloring.
22


MEDICAL
CANNABIDIOL
DISPENSARIES.
The
bill
requires
the
23


department
to
license
by
April
1,
2017,
12
medical
cannabidiol
24


dispensaries
to
dispense
medical
cannabidiol
within
this
state
25


consistent
with
the
provisions
of
the
bill.
The
department
is
26


required
to
license
new
medical
cannabidiol
dispensaries
or
27


relicense
the
existing
medical
cannabidiol
manufacturers
by
28


December
1
of
each
year.
The
bill
contains
provisions
relating
29


to
the
confidentiality
of
the
information
submitted
during
the
30


application
process.
31


The
department
is
directed
to
consider
several
factors
in
32


determining
whether
to
license
a
medical
cannabidiol
dispensary
33


such
as
technical
expertise
and
financial
stability.
Each
34


entity
submitting
an
application
for
licensure
is
required
to
35


-22-


LSB
6011YC
(3)
86


rh/rj


22/
25



H.F.
_____


pay
a
nonrefundable
application
fee
of
$10,000.
1


The
bill
provides
certain
requirements
for
medical
2


cannabidiol
dispensaries
relating
to
location,
dispensation
3


of
medical
cannabidiol,
and
operating
documents.
A
medical
4


cannabidiol
dispensary
is
prohibited
from
engaging
in
certain
5


activities
relating
to
health
care
practitioner
relationships,
6


consumption
on
the
premises,
and
employment
and
shall
be
7


subject
to
reasonable
inspection
and
to
certain
reasonable
8


restrictions
set
by
the
department.
9


Prior
to
dispensing
of
any
medical
cannabidiol,
a
medical
10


cannabidiol
dispensary
is
required
to
verify
that
the
medical
11


cannabidiol
dispensary
has
received
a
valid
medical
cannabidiol
12


registration
card
from
a
patient
or
a
patient’s
primary
13


caregiver,
if
applicable,
assign
a
tracking
number
to
any
14


medical
cannabidiol
dispensed
from
the
medical
cannabidiol
15


dispensary
and
follow
proper
packaging
procedures
in
compliance
16


with
federal
law.
17


FEES.
Medical
cannabidiol
registration
card
fees
and
18


medical
cannabidiol
manufacturer
and
medical
cannabidiol
19


dispensary
application
and
annual
fees
collected
by
the
20


department
shall
be
retained
by
the
department,
and
shall
21


be
used
for
the
purpose
of
regulating
medical
cannabidiol
22


manufacturers
and
medical
cannabidiol
dispensaries
and
for
23


other
expenses
necessary
for
the
administration
of
the
bill.
24


CONFIDENTIALITY.
The
department
is
required
to
maintain
25


a
confidential
file
of
the
names
of
each
patient
and
primary
26


caregiver
issued
a
medical
cannabidiol
registration
card.
27


Individual
names
contained
in
the
file
shall
be
confidential


28


and
shall
not
be
subject
to
disclosure,
except
that
information
29


in
the
confidential
file
may
be
released
on
an
individual
30


basis
to
authorized
employees
or
agents
of
the
department,
the
31


department
of
transportation,
a
medical
cannabidiol
dispensary,
32


and
authorized
law
enforcement
employees
as
necessary
to
33


perform
their
duties.
Release
of
information
must
also
be
34


consistent
with
the
federal
Health
Insurance
Portability
and
35


-23-


LSB
6011YC
(3)
86


rh/rj


23/
25



H.F.
_____


Accountability
Act.
1


ADDITIONAL
DEPARTMENT
DUTIES
——
RULES.
The
bill
requires
2


the
department
to
adopt
rules
relating
to
applications
3


for
medical
cannabidiol
registration
cards,
chronic
and
4


debilitating
diseases
or
medical
conditions,
the
form
and
5


quantity
of
medical
cannabidiol
allowed
to
be
dispensed,
6


requirements
for
the
licensure
of
medical
cannabidiol
7


manufacturers
and
medical
cannabidiol
dispensaries,
a
8


dispensing
system
for
medical
cannabidiol
within
this
state
9


that
follows
certain
requirements,
annual
fees
from
medical
10


cannabidiol
manufacturers
and
medical
cannabidiol
dispensaries
11


public
safety
procedures.
12


RECIPROCITY.
The
bill
provides
that
a
valid
medical
13


cannabidiol
registration
card,
or
its
equivalent,
issued
under
14


the
laws
of
another
state
that
allows
an
out-of-state
patient
15


to
possess
or
use
medical
cannabidiol
in
the
jurisdiction
16


of
issuance
shall
have
the
same
force
and
effect
as
a
valid
17


medical
cannabidiol
card
issued
under
the
bill,
except
that
an
18


out-of-state
patient
in
this
state
shall
not
obtain
medical
19


cannabidiol
from
a
medical
cannabidiol
dispensary
in
this
20


state.
21


USE
OF
MEDICAL
CANNABIDIOL
——
SMOKING
PROHIBITED.
The
bill
22


provides
that
a
patient,
including
an
out-of-state
patient
23


who
is
in
Iowa,
shall
not
consume
the
medical
cannabidiol
by
24


smoking
the
medical
cannabidiol.
25


USE
OF
MEDICAL
CANNABIDIOL
——
AFFIRMATIVE
DEFENSES.
26


The
bill
provides
prosecution
immunity
for
a
health
care
27


practitioner,
a
medical
cannabidiol
manufacturer,
and
a
medical
28


cannabidiol
dispensary,
including
any
authorized
agents
or
29


employees
of
the
health
care
practitioner,
medical
cannabidiol
30


manufacturer,
and
medical
cannabidiol
dispensary,
for
31


activities
undertaken
by
the
health
care
practitioner,
medical
32


cannabidiol
manufacturer,
and
medical
cannabidiol
dispensary
33


pursuant
to
the
provisions
of
the
bill.
34


The
bill
amends
Code
section
124.401,
relating
to
prohibited
35


-24-


LSB
6011YC
(3)
86


rh/rj


24/
25



H.F.
_____


acts
involving
controlled
substances,
to
provide
that
it
is
1


lawful
for
a
person
to
knowingly
or
intentionally
recommend,
2


possess,
use,
dispense,
deliver,
transport,
or
administer
3


medical
cannabidiol
if
the
recommendation,
possession,
use,
4


dispensing,
delivery,
transporting,
or
administering
is
in
5


accordance
with
the
provisions
of
the
bill.
6


The
bill
provides
that
an
agency
of
this
state
or
a
political
7


subdivision
thereof,
including
any
law
enforcement
agency,
8


shall
not
remove
or
initiate
proceedings
to
remove
a
patient
9


under
the
age
of
18
from
the
home
of
a
parent
based
solely
10


upon
the
parent’s
or
patient’s
possession
or
use
of
medical
11


cannabidiol
as
authorized
under
the
bill.
12


PENALTIES.
The
bill
provides
that
a
person
who
knowingly
13


or
intentionally
possesses
or
uses
medical
cannabidiol
in
14


violation
of
the
requirements
of
the
bill
is
subject
to
15


the
penalties
provided
under
Code
chapters
124
and
453B.
A
16


medical
cannabidiol
manufacturer
or
a
medical
cannabidiol
17


dispensary
shall
be
assessed
a
civil
penalty
of
up
to
$1,000
18


per
violation
for
any
violation
of
the
bill
in
addition
to
any
19


other
applicable
penalties.
20


TRANSITION
PROVISIONS.
The
bill
provides
that
a
medical
21


cannabidiol
registration
card
issued
under
Code
chapter
124D
22


(medical
cannabidiol
Act)
prior
to
July
1,
2016,
shall
remain
23


effective
and
continues
in
effect
as
issued
for
the
12-month
24


period
following
its
issuance.
25


REPEAL.
The
bill
repeals
Code
chapter
124D,
the
medical
26


cannabidiol
Act.


27


IMMEDIATE
EFFECTIVE
DATE.
The
bill
takes
effect
upon
28


enactment.


29


-25-


LSB
6011YC
(3)
86


rh/rj


25/
25

